Jeffrey Thomas Elliott Exact Sciences Corp (EXAS) insider trading activity

Jeffrey Thomas Elliott is Chief Financial Officer of EXACT SCIENCES CORP. Currently has a direct ownership of 11,795 shares of EXAS, which is worth approximately $625,960. The most recent transaction as insider was on Feb 24, 2022, when has been sold 5,897 shares (Common Stock) at a price of $70.1 per share, resulting in proceeds of $413,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.8K

0% 3M change

Infinity% 12M change

Total Value Held $625,960

Jeffrey Thomas Elliott Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 24 2022	SELL Open market or private sale	$413,380 $70.1 p/Share	5,897 Reduced 28.61%	14,716 Common Stock
Feb 23 2022	SELL Open market or private sale	$107,511 $69.05 p/Share	1,557 Reduced 16.52%	7,866 Common Stock
Feb 23 2022	BUY Exercise of conversion of derivative security	-	12,747 Added 38.21%	20,613 Common Stock
Feb 22 2022	BUY Exercise of conversion of derivative security	-	3,112 Added 24.83%	9,423 Common Stock
Feb 15 2022	SELL Open market or private sale	$146,292 $79.55 p/Share	1,839 Reduced 22.56%	6,311 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	$311,127 $78.33 p/Share	3,972 Added 32.77%	8,150 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	3,972 Added 48.74%	4,178 Common Stock
Jul 29 2021	SELL Open market or private sale	$4,258,071 $111.0 p/Share	38,361 Reduced 99.47%	206 Common Stock
Apr 30 2021	BUY Grant, award, or other acquisition	$21,263 $103.22 p/Share	206 Added 0.53%	38,567 Common Stock
Mar 03 2021	SELL Open market or private sale	$355,373 $135.02 p/Share	2,632 Reduced 6.42%	38,361 Common Stock
Mar 02 2021	SELL Open market or private sale	$589,493 $139.36 p/Share	4,230 Reduced 9.35%	40,993 Common Stock
Mar 01 2021	SELL Open market or private sale	$1,152,135 $137.11 p/Share	8,403 Reduced 17.29%	40,198 Common Stock
Mar 01 2021	BUY Exercise of conversion of derivative security	-	5,025 Added 10.0%	45,223 Common Stock
Feb 26 2021	BUY Exercise of conversion of derivative security	-	3,437 Added 6.6%	48,601 Common Stock
Feb 24 2021	SELL Open market or private sale	$606,399 $136.3 p/Share	4,449 Reduced 8.97%	45,164 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	-	9,300 Added 15.79%	49,613 Common Stock
Feb 17 2021	SELL Open market or private sale	$288,173 $142.66 p/Share	2,020 Reduced 4.77%	40,313 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	-	3,972 Added 8.58%	42,333 Common Stock

Also insider at

QTRX

Quanterix Corp Healthcare

JTE